![]() |
|
|
Vol. 303, Issue 3, 1199-1205, December 2002
2
-1
Subunit Up-Regulation in Rat Neuropathic Pain Models Correlates with
Antiallodynic Effects of Gabapentin
Departments of Anesthesiology (Z.D.L., E.S.H., C.R.V., Y.-H.S.,
C.I.S., R.R.M.), Pathology (N.A.C., R.R.M.), and Chemistry/Biochemistry
(C.R.V.), University of California San Diego, La Jolla, California
The calcium channel
2
-1 subunit is a structural
subunit important for functional calcium channel assembly. In vitro
studies have shown that this subunit is the binding site for
gabapentin, an anticonvulsant that exerts antihyperalgesic effects by
unknown mechanisms. Increased expression of this subunit in the spinal cord and dorsal root ganglia (DRG) has been suggested to play a role in
enhanced nociceptive responses of spinal nerve-injured rats to
innocuous mechanical stimulation (allodynia). To investigate whether a
common mechanism underlies allodynic states derived from different
etiologies, and if so, whether similar
2
-1 subunit up-regulation correlates with these allodynic states, we compared DRG
and spinal cord
2
-1 subunit levels and gabapentin
sensitivity in allodynic rats with mechanical nerve injuries (sciatic
nerve chronic constriction injury, spinal nerve transection, or
ligation), a metabolic disorder (diabetes), or chemical neuropathy
(vincristine neurotoxicity). Our data indicated that even though
allodynia occurred in all types of nerve injury investigated, DRG
and/or spinal cord
2
-1 subunit up-regulation and
gabapentin sensitivity only coexisted in the mechanical and diabetic
neuropathies. Thus, induction of the
2
-1 subunit in
the DRG and spinal cord is likely regulated by factors that are
specific for individual neuropathies and may contribute to
gabapentin-sensitive allodynia. However, the calcium channel
2
-1 subunit is not the sole molecular change that
uniformly characterizes the neuropathic pain states.
This article has been cited by other articles:
![]() |
H. Epstein-Barash, I. Shichor, A. H. Kwon, S. Hall, M. W. Lawlor, R. Langer, and D. S. Kohane Prolonged duration local anesthesia with minimal toxicity PNAS, April 28, 2009; 106(17): 7125 - 7130. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bordet, B. Buisson, M. Michaud, J.-L. Abitbol, F. Marchand, J. Grist, E. Andriambeloson, M. Malcangio, and R. M. Pruss Specific Antinociceptive Activity of Cholest-4-en-3-one, Oxime (TRO19622) in Experimental Models of Painful Diabetic and Chemotherapy-Induced Neuropathy J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 623 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dray Neuropathic pain: emerging treatments Br. J. Anaesth., July 1, 2008; 101(1): 48 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tuluc, G. Kern, G. J. Obermair, and B. E. Flucher Computer modeling of siRNA knockdown effects indicates an essential role of the Ca2+ channel {alpha}2{delta}-1 subunit in cardiac excitation-contraction coupling PNAS, June 26, 2007; 104(26): 11091 - 11096. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Field, P. J. Cox, E. Stott, H. Melrose, J. Offord, T.-Z. Su, S. Bramwell, L. Corradini, S. England, J. Winks, et al. Identification of the {alpha}2-{delta}-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin PNAS, November 14, 2006; 103(46): 17537 - 17542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsumoto, M. Inoue, A. Hald, W. Xie, and H. Ueda Inhibition of Paclitaxel-Induced A-Fiber Hypersensitization by Gabapentin J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 735 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Rowbotham Editorial II: Gabapentin: a new drug for postoperative pain? Br. J. Anaesth., February 1, 2006; 96(2): 152 - 155. [Full Text] [PDF] |
||||
![]() |
M. C. Rowbotham Mechanisms of neuropathic pain and their implications for the design of clinical trials Neurology, December 29, 2005; 65(12_suppl_4): S66 - S73. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-S. Choi, Y.-C. Kim, Y. J. Lim, C.-J. Lee, P.-B. Lee, S.-C. Lee, W.-S. Sim, and Y.-L. Choi The Neurological Safety of Epidural Gabapentin in Rats: A Light Microscopic Examination Anesth. Analg., November 1, 2005; 101(5): 1422 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Hama and D. Borsook The Effect of Antinociceptive Drugs Tested at Different Times After Nerve Injury in Rats Anesth. Analg., July 1, 2005; 101(1): 175 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Urban, K. Ren, K. T. Park, B. Campbell, N. Anker, B. Stearns, J. Aiyar, M. Belley, C. Cohen, and L. Bristow Comparison of the Antinociceptive Profiles of Gabapentin and 3-Methylgabapentin in Rat Models of Acute and Persistent Pain: Implications for Mechanism of Action J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1209 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gilron, J. M. Bailey, D. Tu, R. R. Holden, D. F. Weaver, and R. L. Houlden Morphine, Gabapentin, or Their Combination for Neuropathic Pain N. Engl. J. Med., March 31, 2005; 352(13): 1324 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Obermair, G. Kugler, S. Baumgartner, P. Tuluc, M. Grabner, and B. E. Flucher The Ca2+ Channel {alpha}2{delta}-1 Subunit Determines Ca2+ Current Kinetics in Skeletal Muscle but Not Targeting of {alpha}1S or Excitation-Contraction Coupling J. Biol. Chem., January 21, 2005; 280(3): 2229 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hansen, I. Gilron, and M. Hong The Effects of Intrathecal Gabapentin on Spinal Morphine Tolerance in the Rat Tail-Flick and Paw Pressure Tests Anesth. Analg., October 1, 2004; 99(4): 1180 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Li, Y.-H. Song, E. S. Higuera, and Z. D. Luo Spinal Dorsal Horn Calcium Channel {alpha}2{delta}-1 Subunit Upregulation Contributes to Peripheral Nerve Injury-Induced Tactile Allodynia J. Neurosci., September 29, 2004; 24(39): 8494 - 8499. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-R. Ji and G. Strichartz Cell Signaling and the Genesis of Neuropathic Pain Sci. Signal., September 28, 2004; 2004(252): re14 - re14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nassar, L. C. Stirling, G. Forlani, M. D. Baker, E. A. Matthews, A. H. Dickenson, and J. N. Wood Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain PNAS, August 24, 2004; 101(34): 12706 - 12711. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mould, T. Yasuda, C. I. Schroeder, A. M. Beedle, C. J. Doering, G. W. Zamponi, D. J. Adams, and R. J. Lewis The {alpha}2{delta} Auxiliary Subunit Reduces Affinity of {omega}-Conotoxins for Recombinant N-type (Cav2.2) Calcium Channels J. Biol. Chem., August 13, 2004; 279(33): 34705 - 34714. [Abstract] [Full Text] [PDF] |
||||